Purpose: Osteoprotegerin (OPG) is a secreted glycoprotein and a member of the tumor necrosis factor (TNF) receptor family that inhibits bone resorption by suppressing osteoclastogenesis. Gingival fibroblasts (GF) play a role in periodontal disease progression, and the purpose of this experiment was to evaluate influence of osteotropic factors on the expression of osteoprotegerin mRNA in these cells. Materials and Methods: In this experiment, the influence of osteoclastogenic factors, interleukin-1 beta (IL-1β ), TNF-α , prostanglandin E2 (PGE2). parathyroid hormone (PTH) and 1α , 25-dihydroxyvitamin D3 on the expression of osteoprotegerin mRNA in GF was studied by Northern blot hybridization. Results: As expected, PGE2 tended to inhibit OPG levels and this was most prominent at 24 hours of culture with 10 -7 M of PGE2. TNF-α at 10ng/ml and also at 25ng/ml decreased OPG levels to almost 30% of the control at 24 hours. This contrasts with reports of increased OPG levels from osteoblast/stromal cells and gingival fibroblasts stimulated by TNF-α . Decrease of OPG levels with PGE2 and TNF-αsuggests a pathway whereby these mediators exert their resorptive effects. However, OPG levels were increased almost 3-fold at 24 hours with IL-1β (1 to 15ng/ml) and increased 1.4 fold with 24-hour treatment of 10 -7 M PTH. Conclusion: Increase of OPG levels suggests that these 'osteoclastogenic' factors act in more complex ways and may act to inhibit bone resorption in inflammatory periodontitis. This result supports the role of OPG as a negative feedback mechanism in osteoclastic activity. (J Korean Acad Periodontol 2008;38:395-404) 
Introduction
Bone is a specialized form of connective tissue that serves as a load-bearing structure and as a mineral reservoir. Four major types of cells are found in bone.
Osteoblasts are cells that are responsible for synthesis of the organic matrix and regulate the mineralization of the bone matrix. Osteocytes are surrounded by the bone matrix and maintain the bone matrix. Bone lining cells cover bone surfaces that are inactive, undergoing neither bone formation nor bone resorption.
Osteoclasts are large, multinucleated cells that func-tion to resorb both the mineral and organic phases of bone. Bone is constantly undergoing remodeling. It is being resorbed by osteoclasts and actively formed by osteoblasts. In health, the amount of bone formed by osteoblasts is equivalent to the amount of bone resorbed by osteoclasts. In some disease states, this balance between resorption and formation can be broken.
Inflammatory periodontitis is one disease that affects the balance of bone metabolism negatively. Of the four main cells in bone, osteoclasts differs in that it does not originate from local progenitor cells, rather it arises from the fusion of mononuclear progenitors of the monocyte/macrophage family of hematopoietic precursor cells. Udagawa et al. 1) showed that osteoclast precursors required cell-to-cell contact with osteoblast/stromal cells to develop into osteoclasts which implied that a membrane-bound molecule existed on the osteoblast/stromal cells. At permissive concentrations of macrophage colony stimulationg factor (M-CSF), the presence of this ligand which was named osteoclast differentiation factor (ODF) 2) (also known as receptor for activation of nuclear factor kappa B ligand (RANKL) 3) , osteoprotegerin ligand (OPGL) 4) and tumor necrosis factor-related, activation-induced cytokine (TRANCE) 5) is sufficient for osteoclastogenesis. RANKL is a membrane-bound homotrimeric protein found on osteoblastic and activated T-cells 6) . Activated T-cells have also been found to secrete it 6) .
The membrane receptor for this ligand is synthesized on osteoclasts and osteoclast precursors and is identical to a receptor discovered in immune cells (RANK) 3, 7) . When RANKL binds to RANK of osteoclast precursors, several signaling pathways such as nuclear factor kappa B (NF-κ B) and c-Jun NH2-terminal kinase (JNK) are activated and differentiation of osteoclast precursors into osteoclasts begins 3, 5) .
For the osteoclast to be fully developed, NF-κ B, c-Fos, and nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1) must be sequentially expressed 8) .
Osteoprotegerin (OPG) is a secreted glycoprotein and a member of the tumor necrosis factor (TNF) receptor superfamily that inhibits bone resorption by suppressing osteoclastogenesis 9) . It is now known that osteoprotegerin acts as a soluble"decoy"receptor that competes with RANKL for RANK. The ratio of the expression level of RANKL molecule to that of the OPG molecule seems to be the decisive factor in osteoclastogenesis 10) . Factors that influence RANKL expression by osteoblasts also regulate OPG expression 11) .
Usually, when RANKL expression is increased, OPG expression is down-regulated, or not up-regulated to the same degree as RANKL so that RANKL/OPG ratio changes in favor of osteoclastogenesis 12) .
Periodontitis, if left unchecked, can ultimately result in loss of teeth due to alveolar bone resorption by osteoclasts. Gingival fibroblasts play a role in periodontal inflammation and the expression of osteoprotegerin mRNA has been observed in the gingival fibroblast 13) . Many cellular events that are involved in bone resorption, both systemic and alveolar, are modulated by a group of osteotropic agents that exert extremely potent effects on bone cells 14) . It would be one more step in elucidating the mechanism of bone resorption, and of alveolar bone resorption in particular, if their effects on gingival fibroblasts could be observed.
In this experiment, the effects of five osteotropic factors, IL-1 β , TNF-α , PGE 2 , parathyroid hormone (PTH), and 1 α ,25-dihydroxyvitamin D3, on osteoprotegerin mRNA expression was studied by Northern blot hybridization. Cultures at 5th to 10th passage were treated with various osteotropic hormones in DMEM/2% FBS. In the first part of the experiment, the cells were exposed to a given concentration each of IL-1 β , TNF-α , PGE2, PTH, and 1 α , 25-dihydroxyvitamin D 3 for 2, 4, 8, or 24 hours. In the second part of the experiment, the cells were exposed to various concentrations of IL-1 β , TNF-α , PTH, PGE 2 and 1 α ,25-dihydroxyvitamin D 3 for 24 hours.
Materials and Methods

Cytokines and hormones
RNA preparation
Total RNA from each culture was isolated using seconds. 500μ l of RPE buffer was added once more to the column and centrifuged for 2 minutes at maximum speed. The column was transferred to a new collection tube and 60μ l of RNAse-free distilled water was added. This was centrifuged for a minute at 8000×g
to elute the RNA. 
Northern blot analysis
Results
The dose-and time-dependent effects of IL-1 β on OPG mRNA expression in gingival fibroblasts are shown in Fig. 1 . OPG levels were slightly decreased at TNF-α tended to decrease OPG mRNA expression levels ( Fig. 4 ). This decrease was slight with 5ng/ml of TNF-α , which reached 81% at 24 hours. With increasing doses of TNF-α at 24 hours, this decrease was increased and became less than one-third of control at 10 and 15ng/ml. 
Discussion
It has been shown in many studies that OPG is produced in various tissues, such as lung, heart, and kidney 9, 15) , and numerous cells, such as bone marrow stromal cells, osteoblastic cells, and lung fibroblasts 15) . Also, human dental mesenchymal cells, such as pulpal cells, periodontal ligamental cells, and gingival fibroblasts have been shown to produce OPG transcripts 14, [16] [17] . Rani and MacDougall 16) have reported that odontoblasts and pulpal cell lines also produced RANKL.
In inflammatory periodontitis, osteoclastic activity is promoted and resulting bone resorption may lead to tooth loss and debilitation. The fact that this destruction of alveolar bone is initiated by bacterial assault is well documented, but there is much to be elucidated about the coordinated regulatory mechanism of the formation and the activity of the osteoclasts. It has been suggested that OPG can suppress osteoclast maturation and activity by binding RANKL/ODF and thereby preventing its interaction with RANK on osteoclasts and osteoclast progenitor cells. Teng et al. 18) have reported that injection of recombinant human osteoprotegerin-fragment crystallizable region (OPG-Fc) fusion protein inhibited alveolar bone resorption and reduced the number of osteoclasts after challenge with Aggregatibacter actinomycetemcomitans in mice. A wide array of hormones and cytokines involved in the regulation of bone resorption do not act directly on osteoclasts but exerts its effects via other cells such as osteoblasts. In this study, the effects of 5 osteotropic molecules on OPG mRNA expression levels in the gingival fibroblasts have been studied.
IL-1 β is a principal mediator of inflammatory reactions acting on many cell types and this cytokine is increased in the gingiva of adult periodontitis subjects compared with clinically healthy gingiva. Also, IL-1 β levels are elevated in active periodontitis sites compared to stable inflamed sites 19) . IL-1 β has the potential to initiate tissue destruction and bone loss in periodontal diseases. It is the most potent known inducer of bone demineralization and synergizes with tumor necrosis factor alpha in stimulating bone resorption as well as major changes in the connective tissue matrix 20) . One study has shown that the rate of IL-1 β messenger RNA was higher in the connective tissue furthest from the pocket epithelium, suggesting a role in the alveolar bone resorption that occurs in periodontal disease 21) . Another study has demonstrated that administration of IL-1 β accelerated alveolar bone destruction in ligature-induced periodontal tissue inflammation in rats over a 2-week period 22) .
Contrary to expectations as cytokines stimulating
osteoclast-ogenesis were usually reported to decrease OPG levels albeit in different cell types 23) , IL-1 β is known to increase levels of OPG mRNA expression in various cells. Sakata et al 13) have reported this increase with gingival fibroblasts, Hofbauer et alʼs 24) s study also shows increased OPG mRNA expression in human osteoblastic cells. The result of this study also show that stimulation with Il-1 β increased OPG mRNA expression in gingival fibroblasts. This suggests that Il-1 β acts not only to stimulate resorption of bone but may act to also inhibit it and it also supports the role of OPG as a negative feedback mechanism for the reduction of osteoclastic activity 24) .
Prostaglandins play a role in inflammatory periodontitis. Of the prostaglandins, PGE2 is the most potent stimulator of bone resorption. This shows a wide range of proinflammatory actions and its effects are enhanced by synergisms with other inflammatory mediators. PGE 2 levels reflect the disease status of the periodontium. PGE 2 -induced bone resorption may be explained by this mechanism. Also PGE2 inhibited OPG formation in various cell types such as mouse calvarial cells 25) and human bone marrow stromal cells 26) . Other studies have shown PGE2 having a crucial role in RANKL-dependent osteoclastogenesis induced by LPS or bacterial sonicates 27) .
PTH tended to increase OPG mRNA levels in this experiment. It was reported by Ogata et al 28) that gingival fibroblasts lack PTH receptors as these cells did not produce cAMP when stimulated by PTH. This is by no means conclusive, as different density of PTH receptors may result in different signal transduction pathways being stimulated. This result is puzzling as PTH acts to increase extracelluar ionized calcium levels directly through its actions on kidney and bone.
PTH tended to inhibit production of OPG activity in mouse calvarial bone 25) and also in various osteoblastic cell lines 29) . TNF-α decreased OPG mRNA levels in this study.
This result, while expected, is contrary to the results reported by Sakata et al 13) . In their study, 3ng/ml of TNF-α increased OPG levels to 210% at 24 hours.
Studies by Nakashima et al 23, 24) show that OPG mRNA levels in stromal cells increased when stimulated with TNF-α . Wadaʼs study with PDL fibroblasts stimulated with LPS shows induction of TNF-α results in increase of both OPG and RANKL levels, but increase of OPG production was greater 30) . Brandstromʼs study 26) shows OPG levels decreasing when stimulated with TNF-α . Results from this study suggest that TNF-α , a potent stimulator of bone resorption may exert its effects by this way.
Vitamin D is a principal factor required for the development and maintenance of bone as well as for maintaining normal calcium homeostasis. In this study, 1 α ,25-dihydroxyvitaminD3 tended to inhibit OPG mRNA expression slightly at greater than 10 -8 M concentration. It is difficult to say if this observed change is meaningful or not. In a study by Hofbauer et al 24) 1α ,25-dihydroxyvitaminD 3 increased OPG mRNA levels by 90 and 50% in fetal osteoblastic cells and normal trabecular osteoblastic cell but did not affect OPG mRNA levels in marrow stromal preosteoblastic cells. Some have reported decreased OPG levels when dermal fibroblasts were stimulated with both 1 α ,25-dihydroxyvitaminD 3 and dexamethasone 31) and when stromal cells were stimulated with 1 α ,25-dihydroxyvitaminD3 and dexamethasone 32) .
Horwood has reported that 1 α ,25-dihydroxyvitaminD 3 decreased OPG mRNA formation in osteoblastic cell lines 29) . Suda 33) and OPG is a way that offers therapeutic possibilities in many different bone diseases 34, 35) and in case of osteoporosis and rheumatoid arthritis, clinical trials are being undertaken [36] [37] [38] . Further study is required before this novel approach may be used in periodontal therapy.
In this experiment, OPG mRNA expression by gingival fibroblasts which may act as a local suppressor of bone resorption, was influenced by IL-1 β , PGE2, PTH, TNF-α , and 1α ,25-dihydroxyvitaminD 3 . These osteotropic factors may influence bone resorption by control of OPG levels.
